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The process of assessing the public health risk of ex-
posure to particular environmental contaminants is
complicated and full of assumptions and uncertainties
(1,2). However, the problems of assessing risks for
chromium exposure are unusually complex (3,4). The
problems posed by current investigations ofchromium-
contaminated soil in northern New Jersey (5), in part,
provided the impetus for a conference on a research
agenda for chromium contamination and risk assess-
ment.
During the first halfofthe present century, northern
New Jersey was the chromite-chromate industrial
capital of the world, and we face today the legacy of
chromium-containing slag left by this industry and dis-
tributed gratis to many locations and communities in
Hudson County. The magnitude of this waste problem
measured in millions of tons at dozens of sites is stag-
gering (5), but this conference (to the disappointment
of some) is not about New Jersey per se but about the
generic environmental health problems posed by chro-
mium in the environment and the resultant human ex-
posure and health risks.
Chromium, because ofits unique properties, was rap-
idly exploited for many purposes, first as a mordant
and oxidizer in the dyeing industry, later in tanning,
and then in metallurgy for its alloying properties with
iron, and even more recently for its metal-plating pro-
perties (6).
Chromium has been in commercial use for less than
300 years. It is a rather rare mineral in the earth's
crust, with only a few deposits around the world prov-
ing economically exploitable. Although it does not have
a long history comparable to lead, iron, or mercury, for
example, it appears to be making up for this lack of
history by providing major challenges for exposure and
risk assessment and public health policy.
The greatest challenge of chromium for the risk as-
sessor, and certainly for the risk communicator, lies in
the differential toxicity and carcinogenicity oftrivalent
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and hexavalent chromium (7). For the risk communica-
tor, the fact that hexavalent chromium is a potent car-
cinogen while trivalent chromium is an essential trace
element poses a major problem. It is not surprising that
lay persons would be troubled by this paradox, but it
would be far simpler for the professional if one could
ascertain with confidence whether a particular exposure
scenario involves primarily the hexavalent or trivalent
form. To complicate matters, among hexavalent salts it
appears to be the partially soluble salts (i.e., zinc chro-
mate) that are more carcinogenic than either the in-
soluble salts (e.g., lead chromate) or the soluble ones
(e.g., sodium or potassium chromates and dichro-
mates) (8).
The fact that chromium exists in several oxidation
states in the environment and the body is certainly not
unique. However, the propensity ofchromium to change
oxidation states, both in environmental media and in
living cells, requires far better understanding of the
redox environments and poses a major challenge to the
analytical laboratory. Two different laboratories ana-
lyzing the same soil sample have been known to report
the chromium content as almost entirely hexavalent in
one case and entirely trivalent in the other. Even a
novice may guess that this discrepancy arises from dif-
ferent ways of handling, digesting, or extracting the
sample, such that oxidation (or reduction) may occur in
the laboratory itself. But clearly, research is required
to establish sound and reproducible analytical protocols
that can be replicated reliably in standard environmen-
tal laboratories. These must apply not only to air and
water but to complex environmental and biological ma-
trices. Thus, an examination of the research needs for
analysis ofchromium was recognized as one major focus
ofthe conference.
The process of risk assessment is outlined in various
ways, partially depending on whether one focuses on
cancer or other health end points. However, the general
format involves four steps (1) variously referred to as
follows:
a) hazard identification and evaluation (determining
one or more hazardous substances and defining the
end points ofinterest);4 M. GOCHFELD
b) hazard quantification or dose-response determina-
tion (reviewing toxicologic and epidemiologic lit-
erature to relate particular responses to particular
levels ofexposure or dose);
c) exposure assessment (completing an exposure ma-
trix that takes into account the routes ofexposure
and the media of exposure and establishing expo-
sure scenarios);
d) risk characterization (or analysis or estimation) in
which one combines the dose-response information
with the exposure assessment to determine the
level ofrisk to one or more target populations under
one or more exposure scenarios.
A comprehensive risk assessment involves the con-
sideration of several sources or routes of exposure and
different target populations with different exposure
contexts (durations or conditions of exposure) and dif-
ferent susceptibilities (children, workers, asthmatics,
etc.). Yet often only one or two components turn out to
drive the risk assessment, contributing the major risk
to the overall estimate. Certainly for industrial expo-
sure scenarios, inhalation ofhexavalent chromium lead-
ing to lung cancer turns out to be the major component
ofthe overall risk, and the only one dealt with in many
studies. However, for community exposure to chromium-
contaminated soil, inhalation is less likely to dominate
the exposure scenarios unless the soil is dry and dusty.
Ingestion ofsoil by children, for example, may turn out
to dominate the risk assessment as it does for 2,3,7,8
tetrachlorodibenzo-p-dioxin-contaminated soil (9).
Clearly, the process of hazard identification for chro-
mium requires accurate determination of the oxidation
state ofthe compound in nature, as well as identification
of which hexavalent salt(s) is present. Establishing the
form and content of a toxic material in environmental
media is the first requisite for understanding its health
consequences. What happens to the chromium when it
enters the body is also important for several reasons.
It is well established that Crvl is a lung carcinogen
(10), with some studies (particularly early ones) of
chromium-exposed workers showing a relative risk of
more than nearly 20-fold (8,11). Yet it has proven very
difficult to mimic this in animal models. A reliable inha-
lation model for Crvy and pulmonary carcinogenesis re-
mains to be developed, and since positive results were
achieved with calcium chromate but not with soluble
chromates, attention should focus on those chromates
already implicated as carcinogens in epidemiologic
studies (3,8). Moreover, although we know that inhala-
tion of hexavalent chromium is associated with a high
risk of lung cancer, both epidemiologic and toxicologic
research to date are unclear on the cancer potential
associated with ingestion or dermal absorption of
hexavalent chromium compounds or on the cancer risk
to other organ systems.
Since in many risk assessments, particularly where
children are involved, soil ingestion may be a primary
route ofexposure, this raises the question ofthe cancer
risk associated with ingestion ofhexavalent compounds.
Understanding how chromium behaves in the body, and
particularly how the genotoxic effects of chromium are
manifested, is therefore ofparticular importance. It is a
reasonable guess that the potent carcinogenic effect of
hexavalent chromium is somehow related to the redox
reactions that proceed in the cell. The fact that
hexavalent chromium freely enters cells, while trivalent
chromium apparently does not, raises additional ques-
tions regarding the mechanism of chromium toxicity
and carcinogenicity.
Understanding the mechanisms ofchromium carcino-
genicity is an important requirement for designing a
risk assessment, while obtaining better epidemiologic
or toxicologic evidence regarding the carcinogenic ef-
fects by routes other than inhalation is clearly another
research priority.
Similarly, there is a need to sort out the impact of
dermal exposure and dermal absorption of chromium.
Although occupational dermatology has traditionally
distinguished between sensitization and irritation in
causing contact versus irritant dermatitis, it is not at
all clear how this distinction operates in the case of
chromium since some compounds are suspected ofbeing
potent sensitizers whereas others are know irritants.
Moreover, if dermal responsiveness to chromium is
widespread, it (rather than cancer) may prove to be the
health effect that drives policy regarding mitigation and
reduction of exposure. Setting a research agenda for
chromium is not intended to solve specific environmental
chromium problems, but to identify what information
we need in order to make sound judgments regarding
chromium in our environment or chromium in our lives.
Ultimately, to make sensible decisions about risks as-
sociated with chromium in the environment it is essential
to a) establish the form and quantity of chromium in
the environment and assess its bioavailability; b) estab-
lish the routes of exposure and how these might affect
the chromium species to which individuals are exposed;
c) distinguish each of the exposure sites, skin, lungs,
and intestinal tract, as target organs on the one hand or
routes of exposure on the other; d) understand the
mechanisms by which the different chromium species
exert toxic effects and the conditions under which these
effects are manifest. This conference is designed to
identify those components of the puzzle that require
further research attention.
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